ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 716771 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 716771; 2) Community: the network communities that were significantly associated with the response to NSC 716771; 3) Molecule: the relationships between components within communities and NSC 716771; 4) MDR: the compounds that were significantly associated with the NSC 716771.

NSC Compound Enrichment Correlation
NSC 627744 Null 0.0163859626459254 0.2558549
NSC 629868 Null 0.0163859626459254 -0.1324984
NSC 631542 Null 0.0163859626459254 0.27740574
NSC 638748 Tetrakis(8-chinolineolato)titanium(IV)-tetrahydrochloride 0.0163859626459254 0.18372249
NSC 670783 Null 0.0163859626459254 0.18990457
NSC 679005 2-Butenedioic acid, 2,2'-(2,4-dioxopyrimidine-1,3-diyl)bis-, tetraethyl ester 0.0163859626459254 0.14778861
NSC 685989 Dihydroartemisinyl ether, stereoisomer of NSC-685988 0.0163859626459254 0.30809849
NSC 702047 2-Propenone, 1,1'-(2,5-pyridinediyl)bis[3-(2-furanyl)- 0.0163859626459254 0.20746877
NSC 724794 5-Benzyl-9-hydroxy-5H-indeno[1,2-b]indol-10-one 0.0174563696971636 0.12650057
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.0174563696971636 0.22247967
Total:83  Current:30    [First] [Prev] [Next] [Last]